Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

[1] Orelabrutinib (Orelabrutinib)

[1] Orelabrutinib (Orelabrutinib) 💬

[1] BTK 💬

[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬

[4] 13, 49, 61, 63 💬

2

Orelabrutinib (High Dose)

[1] Orelabrutinib (Orelabrutinib)

[1] Orelabrutinib (Orelabrutinib) 💬

[1] BTK 💬

[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬

[1] 49 💬

3

Orelabrutinib (Low Dose)

[1] Orelabrutinib (Orelabrutinib)

[1] Orelabrutinib (Orelabrutinib) 💬

[1] BTK 💬

[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬

[1] 49 💬

4

Orelabrutinib( higher dose)

[1] Orelabrutinib (Orelabrutinib)

[1] Orelabrutinib (Orelabrutinib) 💬

[1] BTK 💬

[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬

[1] 63 💬

5

Orelabrutinib( lower dose)

[1] Orelabrutinib (Orelabrutinib)

[1] Orelabrutinib (Orelabrutinib) 💬

[1] BTK 💬

[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬

[1] 63 💬